SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-12-007761
Filing Date
2012-02-08
Accepted
2012-02-08 14:46:30
Documents
1
Group Members
ALAN E. SALZMANVANTAGEPOINT VENTURE ASSOCIATES IV, L.L.C.VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND, L.P.VANTAGEPOINT VENTURE PARTNERS IV, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a12-4364_2sc13da.htm SC 13D/A 147964
  Complete submission text file 0001104659-12-007761.txt   149672
Mailing Address 1001 BAY HILL DRIVE SUITE 300 SAN BRUNO CA 94066
Business Address 1001 BAY HILL DRIVE SUITE 300 SAN BRUNO CA 94066 6508663100
VANTAGEPOINT VENTURE PARTNERS IV Q LP (Filed by) CIK: 0001129585 (see all company filings)

IRS No.: 943359388 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Subject) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85368 | Film No.: 12581395
SIC: 2834 Pharmaceutical Preparations